Market revenue in 2023 | USD 129.9 million |
Market revenue in 2030 | USD 200.2 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Autotransfusion systems |
Fastest growing segment | Autotransfusion Systems |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Autotransfusion Systems |
Key market players worldwide | Atrium Health, Becton Dickinson & Co, Beijing Enterprises Holdings Ltd, Fresenius SE & Co KGaA, LivaNova PLC, Medtronic PLC, Teleflex Inc, Redax |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to autotransfusion devices market will help companies and investors design strategic landscapes.
Autotransfusion systems was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe autotransfusion devices market based on autotransfusion systems covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe autotransfusion devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe autotransfusion devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account